[Clinical practice guidelines for standardized management of stillbirth (2026 edition)]

Stillbirth is one of the most common adverse pregnancy outcomes. It not only causes physical and psychological trauma to pregnant and puerperal women but also imposes heavy family and socioeconomic burdens. Standardized clinical management of stillbirth is crucial for improving the quality of the birth population. Such management should be based on a multidisciplinary collaborative diagnosis and treatment model, covering a complete pathway including high-risk factor screening, risk stratification and early warning, whole-pregnancy monitoring, and intervention in subsequent pregnancies. Accordingly, this guideline was jointly developed by the Fetal Medicine Group of the Chinese Society of Perinatal Medicine (Chinese Medical Association), the National Obstetric Quality Control Center, and the National Clinical Research Center for Obstetric and Gynecologic Diseases of China. We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system and international reporting standards for practice guidelines. A multidisciplinary expert team was established to systematically review evidence on 32 key clinical questions in China and formulate evidence-based recommendations, so as to provide guidance for the standardized management of stillbirth in China. This guideline aims to provide a knowledge framework and practical guidance for primary healthcare professionals, obstetricians, clinical pharmacists, nurses at all levels of medical institutions, as well as pregnant women and their families.